Exenatide does not slow Parkinson’s disease progression compared to placebo
1. There was no significant difference in functional outcome between both groups at 96 weeks. 2. Exenatide was safe and ...
1. There was no significant difference in functional outcome between both groups at 96 weeks. 2. Exenatide was safe and ...
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
1. In this randomized controlled trial, lixisenatide reduced motor disability progression in Parkinson’s patients. 2. Individuals in the lixisenatide group ...
1. In this systematic review, Parkinson’s disease patients with freezing of gait (FOG) experienced overall worse sleep quality, increased daytime ...
Sugar-sweetened beverage intake may be associated with lower sleep duration in children 1. In this cross-sectional study, household food insecurity ...
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
1. In a retrospective study examining 50,000 optical coherence tomography (OCT) images from a large database, thicknesses of several different ...
1. In this systematic review and meta-analysis, palliative care helped alleviate symptom burden and provided greater satisfaction for patients with ...
Click here to read this study in NEJM
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.